Individuals with gastrointestinal disorders such as Crohns disease or celiac disease are likely to suffer from impaired B12 absorption
The clinical data showed the 4 mg group achieving 17.1% body weight reduction at 48 weeks, which already exceeds what most single-receptor GLP-1 agonists deliver at their maximum doses
Trimethylamine-N-oxide: friend, foe, or simply caught in the cross-fire
DSIP has been studied in a range of peptide research environments involving neuropeptide signalling pathways, neurological biochemical investigations, and peptide-protein interaction mechanisms
Common ZEPBOUND side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, injection site reactions, fatigue, allergic responses, belching, hair loss, and heartburn, though this is not an exhaustive list of potential ZEPBOUND side effects